Hosted on MSN2d
Health Canada approves MedMira’s rapid test for HIV and syphilis
The test enables healthcare professionals to identify HIV-1/2 and syphilis antibodies from a single finger prick sample.
MedMira receives Health Canada approval for its Multiplo(R) Rapid (TP/HIV) Test for Syphilis and HIV
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, ...
MedMira Gains Health Canada Approval for Rapid Test
Medmira (TSE:MIR) has released an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended by top Wall Street analysts, ...
WSIL-TV1mon
MedMira Reports FY2024 Fourth Quarter and Year End Financial Results
HALIFAX, NS / ACCESSWIRE / November 28, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the financial year ended July 31, 2024. Corporate Update In December ...
Pharmabiz1d
Health Canada approves MedMira’s Multiplo Rapid TP/HIV test for Syphilis and HIV
Health Canada approves MedMira’s Multiplo Rapid TP/HIV test for Syphilis and HIV: Halifax, Canada Friday, December 27, 2024, 10:00 Hrs [IST] MedMira Inc. (MedMira), a leading de ...
PharmiWeb29d
MedMira Reports FY2024 Fourth Quarter and Year End Financial Results
HALIFAX, NS / ACCESSWIRE / November 28, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the financial year ended July 31, 2024. In December 2023, the Company ...